ADXN
Addex Therapeutics Ltd ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$6.88
+0.14 ▲ +2.08%
🌙 3월 13일 6:55 PM ET (한국 3/14 07:55)
$7.22
+0.34 ▲ +4.94%
| Index | - | P/E | - | EPS (ttm) | -8.43 | Insider Own | 0.03% | Shs Outstand | 0.00B | Perf Week | -4.04% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -10.88% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 0.05% | Short Float | 0.95% | Perf Quarter | -9.29% |
| Income | -0.01B | P/S | 45.63 | EPS this Y | - | Inst Trans | 35.92% | Short Ratio | 2.26 | Perf Half Y | -21.64% |
| Sales | 0.00B | P/B | 0.89 | EPS next 5Y | - | ROA | -62.09% | Short Interest | 0.01M | Perf YTD | -10.88% |
| Book/sh | 7.7 | P/C | 3.15 | EPS past 3/5Y | - | ROE | -71.25% | 52W High | -42.9% ($12.05) | Perf Year | -3.1% |
| Cash/sh | 2.18 | P/FCF | - | Sales past 3/5Y | -47.46% -30.4% | ROIC | -95.92% | 52W Low | 5.68% ($6.51) | Perf 3Y | -67.55% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -223.53% | Gross Margin | 133.13% | Volatility(W/M) | 2.76% 3.55% | Perf 5Y | -96.81% |
| Dividend TTM | - | EV/Sales | 31.41 | Sales Y/Y TTM | -72.15% | Oper. Margin | -1573.7% | ATR (14) | 0.37 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.01 | EPS Q/Q | 2.58% | Profit Margin | -3861.27% | RSI (14) | 41.06 | Recom | 4.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.01 | Sales Q/Q | -7.96% | SMA20 | -6.12% ($7.33) | Beta | 1.47 | Target Price | $22.87 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 12000000 | SMA50 | -11.09% ($7.74) | Rel Volume | 0.26 | Prev Close | $6.74 |
| Employees | 2 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | - | SMA200 | -17.1% ($8.3) | Avg Volume(3M) | 0.01M | Price | $6.88 |
| IPO | 2020/1/29 | Option/Short | No/Yes | Trades | 45 | Volume | 1,399 | Change | 2.08% |
뉴스 로딩 중...